Quadramet is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Lantheus Medical Imaging, Inc.. The primary component is Samarium Sm-153 Lexidronam Pentasodium.
Product ID | 11994-016_3f73e214-cad4-4b6d-b1ed-66f1777b57f4 |
NDC | 11994-016 |
Product Type | Human Prescription Drug |
Proprietary Name | Quadramet |
Generic Name | Samarium Sm 153 Lexidronam |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1997-05-19 |
Marketing Category | NDA / NDA |
Application Number | NDA020570 |
Labeler Name | Lantheus Medical Imaging, Inc. |
Substance Name | SAMARIUM SM-153 LEXIDRONAM PENTASODIUM |
Active Ingredient Strength | 50 mCi/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1997-05-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020570 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-05-19 |
Ingredient | Strength |
---|---|
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM | 50 mCi/mL |
SPL SET ID: | 61e84808-0999-4923-910c-2a480d5f971a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
QUADRAMET 78374967 2897509 Live/Registered |
LANTHEUS MEDICAL IMAGING, INC. 2004-02-26 |
QUADRAMET 74653588 2046461 Dead/Cancelled |
CYTOGEN Corporation 1995-03-30 |